Investor Overview

Corporate Profile

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company that is seeking to unlock the full potential of biologic therapies by avoiding unwanted immune responses. Selecta’s tolerogenic Synthetic Vaccine Particles (SVP™) technology platform is designed to enable a range of novel biologics for rare and serious diseases that require new treatment options. The company’s current proprietary pipeline includes SVP-enabled enzyme, oncolo... View more »

Recent News
View all press releases »
Presentations
Download DocumentationOct 18, 2017
ESGCT 2017 OTC Poster
Download DocumentationOct 18, 2017
ESGCT 2017 MMA Poster
Download DocumentationSept 12, 2017
Selecta September 2017 Investor Presentation
Upcoming Events
There are currently no events scheduled.
View all events »
Stock Quote
NASDAQ GS :  SELB (Common Stock)
$21.31
- 0.69 (3.14%)
Stock chart for: SELB.O.  Currently trading at $21.31 with a 52 week high of $28.00 and a 52 week low of $10.27.
Data as of Oct 20, 2017 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
IR Contact
Jason Fredette
Selecta Biosciences
Phone: 1 617 231 8078
E-mail: JFredette@selectabio.com

Data provided by Nasdaq. Minimum 15 minutes delayed.
Back to Top